These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 2293877)
41. Cytogenetics and molecular genetics of carcinomas arising from thyroid epithelial follicular cells. Pierotti MA; Bongarzone I; Borello MG; Greco A; Pilotti S; Sozzi G Genes Chromosomes Cancer; 1996 May; 16(1):1-14. PubMed ID: 9162191 [TBL] [Abstract][Full Text] [Related]
42. Gains of chromosomes 7, 17, 12, 16, and 20 and loss of Y occur early in the evolution of papillary renal cell neoplasia: a fluorescent in situ hybridization study. Brunelli M; Eble JN; Zhang S; Martignoni G; Cheng L Mod Pathol; 2003 Oct; 16(10):1053-9. PubMed ID: 14559990 [TBL] [Abstract][Full Text] [Related]
43. Cytogenetic and molecular genetic studies of follicular and papillary thyroid cancers. Herrmann MA; Hay ID; Bartelt DH; Ritland SR; Dahl RJ; Grant CS; Jenkins RB J Clin Invest; 1991 Nov; 88(5):1596-604. PubMed ID: 1939648 [TBL] [Abstract][Full Text] [Related]
44. Significance of trisomy 7 and 12 in thyroid lesions with follicular differentiation: a cytogenetic and in situ hybridization study. Roque L; Serpa A; Clode A; Castedo S; Soares J Lab Invest; 1999 Apr; 79(4):369-78. PubMed ID: 10211989 [TBL] [Abstract][Full Text] [Related]
45. Synchronous and Metastatic Papillary and Follicular Thyroid Carcinomas with Unique Molecular Signatures. Cracolici V; Mujacic I; Kadri S; Alikhan M; Niu N; Segal JP; Rosen LE; Sarne DH; Morgan A; Desouky S; Cipriani NA Endocr Pathol; 2018 Mar; 29(1):9-14. PubMed ID: 28710706 [TBL] [Abstract][Full Text] [Related]
46. Significant correlation of telomerase activity in thyroid papillary carcinomas with cell differentiation, proliferation and extrathyroidal extension. Okayasu I; Osakabe T; Fujiwara M; Fukuda H; Kato M; Oshimura M Jpn J Cancer Res; 1997 Oct; 88(10):965-70. PubMed ID: 9414658 [TBL] [Abstract][Full Text] [Related]
47. Follicular variant of papillary thyroid carcinoma: genome-wide appraisal of a controversial entity. Wreesmann VB; Ghossein RA; Hezel M; Banerjee D; Shaha AR; Tuttle RM; Shah JP; Rao PH; Singh B Genes Chromosomes Cancer; 2004 Aug; 40(4):355-64. PubMed ID: 15188460 [TBL] [Abstract][Full Text] [Related]
48. Immunohistochemical analysis of the ras oncogene protein product in human thyroid neoplasms. Papadimitriou K; Yiagnisis M; Tolis G; Spandidos DA Anticancer Res; 1988; 8(6):1223-7. PubMed ID: 3064713 [TBL] [Abstract][Full Text] [Related]
49. DNA copy number changes in thyroid carcinoma. Hemmer S; Wasenius VM; Knuutila S; Franssila K; Joensuu H Am J Pathol; 1999 May; 154(5):1539-47. PubMed ID: 10329606 [TBL] [Abstract][Full Text] [Related]
50. Chromosomal changes in thyroid tumors. Relation with DNA content, karyotypic features, and clinical data. Teyssier JR; Liautaud-Roger F; Ferre D; Patey M; Dufer J Cancer Genet Cytogenet; 1990 Dec; 50(2):249-63. PubMed ID: 2265404 [TBL] [Abstract][Full Text] [Related]
51. Flow cytometric DNA measurement in benign and malignant human thyroid tissues. Mizukami Y; Nonomura A; Michigishi T; Kosaka T; Noguchi M; Nakamura S; Hashimoto T Anticancer Res; 1992; 12(6B):2213-7. PubMed ID: 1295468 [TBL] [Abstract][Full Text] [Related]
53. Numerical chromosomal aberrations in papillary renal cortical tumors: relationship with histopathologic features. Henke RP; Erbersdobler A Virchows Arch; 2002 Jun; 440(6):604-9. PubMed ID: 12070600 [TBL] [Abstract][Full Text] [Related]
54. Cytogenetic findings on eight follicular thyroid adenomas including one with a t(10;19). Bartnitzke S; Herrmann ME; Lobeck H; Zuschneid W; Neuhaus P; Bullerdiek J Cancer Genet Cytogenet; 1989 May; 39(1):65-8. PubMed ID: 2731149 [TBL] [Abstract][Full Text] [Related]
55. Morphological aspects of thyroid cancer and tumour prognosis. Williams D J Endocrinol Invest; 1995 Feb; 18(2):153-4. PubMed ID: 7629386 [No Abstract] [Full Text] [Related]
56. Immunohistochemical analysis of nm23 protein expression in thyroid papillary carcinoma and follicular neoplasm. Tabriz HM; Adabi Kh; Lashkari A; Heshmat R; Haghpanah V; Larijani B; Tavangar SM Pathol Res Pract; 2009; 205(2):83-7. PubMed ID: 18996649 [TBL] [Abstract][Full Text] [Related]
57. Frequency and degree of aneuploidy in benign and malignant thyroid neoplasms. Schelfhout LJ; Cornelisse CJ; Goslings BM; Hamming JF; Kuipers-Dijkshoorn NJ; van de Velde CJ; Fleuren GJ Int J Cancer; 1990 Jan; 45(1):16-20. PubMed ID: 2298499 [TBL] [Abstract][Full Text] [Related]
58. [Morphologic and molecular-genetic characteristics of carcinoma, adenoma and surrounding tissue of the thyroid gland]. Pal'tsev MA; Kogan EA; Tuntsova OI; Severin ES; Silaeva SA; Golenchenko VA Arkh Patol; 1998; 60(3):5-10. PubMed ID: 9702292 [TBL] [Abstract][Full Text] [Related]
59. Prevalences of Gs alpha, ras, p53 mutations and ret/PTC rearrangement in differentiated thyroid tumours in a Korean population. Park KY; Koh JM; Kim YI; Park HJ; Gong G; Hong SJ; Ahn IM Clin Endocrinol (Oxf); 1998 Sep; 49(3):317-23. PubMed ID: 9861322 [TBL] [Abstract][Full Text] [Related]
60. Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification. Zhou M; Yang XJ; Lopez JI; Shah RB; Hes O; Shen SS; Li R; Yang Y; Lin F; Elson P; Sercia L; Magi-Galluzzi C; Tubbs R Am J Surg Pathol; 2009 Dec; 33(12):1840-9. PubMed ID: 19898225 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]